NON-SMALL-CELL LUNG
Clinical trials for NON-SMALL-CELL LUNG explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL-CELL LUNG trials appear
Sign up with your email to follow new studies for NON-SMALL-CELL LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First patients to receive new cancer drug in groundbreaking safety trial
Disease control Recruiting nowThis is the first-ever study in people for a new drug called EPI-326. It aims to find a safe dose and see how the body handles the drug in patients with advanced lung cancer (with a specific genetic change called EGFR mutation) or advanced head and neck cancer. The main goal is t…
Matched conditions: NON-SMALL-CELL LUNG
Phase: PHASE1 • Sponsor: EpiBiologics • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Smart cell therapy aims to target cancer while sparing healthy tissue
Disease control Recruiting nowThis study is testing a new type of cell therapy called A2B395 for adults with advanced solid tumors that have spread or returned. The therapy uses modified immune cells designed to specifically kill cancer cells while protecting the patient's healthy cells. The main goals are to…
Matched conditions: NON-SMALL-CELL LUNG
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC